Table 2 Complications and outcomes of the AP patients with or without IPN
From: Reduced lymphocyte count as an early marker for predicting infected pancreatic necrosis
Non-IPN group (n = 123) | IPN group (n = 30) | p Value | |
|---|---|---|---|
Severity of AP, no. (%) | <0.001 | ||
Mild | 59 (48.0) | 0 (0) | |
Moderate | 26 (21.1) | 0 (0) | |
Severe | 38 (30.9) | 4 (13.3) | |
Critical | 0 (0) | 26 (86.7) | |
Organ dysfunction, no. (%) | |||
Respiratory | 34 (27.6) | 19 (63.3) | <0.001 |
Renal | 20 (16.3) | 22 (73.3) | <0.001 |
Cardiovascular | 5 (4.1) | 12 (40.0) | <0.001 |
Mechanical ventilation, no. (%) | 21 (17.1) | 18 (60.0) | <0.001 |
CRRT, no. (%) | 20 (16.3) | 19 (63.3) | <0.001 |
Complication, no. (%) | |||
Pancreatic pseudocyst | 8 (6.5) | 1 (3.3) | 1.000 |
Invasive fungal infection | 0 (0) | 2 (6.7) | 0.037 |
Intra-abdominal hemorrhage | 1 (0.8) | 9 (30.0) | <0.001 |
Deep vein thrombosis | 5 (4.1) | 2 (6.7) | 0.624 |
Portal thrombosis | 1 (0.8) | 1 (3.3) | 0.355 |
IAH | 6 (4.9) | 8 (26.7) | 0.001 |
Encephalopathy | 1 (0.8) | 0 (0) | 1.000 |
Fistula | 0 (0) | 5 (16.7) | <0.001 |
Hospital stay, days | 10 (6, 14) | 30 (18, 54) | <0.001 |
ICU stay, days | 6 (3, 9) | 17 (9, 48) | <0.001 |
Mortality rate, no. (%) | 4 (3.3) | 13 (43.3) | <0.001 |